INVA Innoviva, Inc.
$20.66▲ +0.19%
Healthcare
Other
After hours
$20.66▲ +0.00%
Sep 11, 7:30 PM ET
Volume 727.3K
Avg Volume (10D) 717.3K
Key Metrics & Fundamentals
Market Cap
$1.49B
P/E Ratio
4.8
Div Yield
–%
52W Range
16.52 - 25.15
% vs 50 MA
-3.06%
% vs 200 MA
-5.10%
RSI-14
41.0
MACD Histogram
-0.0200
Beta (1Y vs SPY)
-0.03
Free Cash Flow
$51.54M
Gross Rev
$119.59M
Gross Profit
$90.62M
EBITDA
-$66.77M
COGS
$28.98M
Operating Exp
$39.76M
Operating Income
$50.86M
EBIT
$50.86M
Pretax Income
-$108.02M
Net Income
-$83.42M
EPS (Diluted)
-1.14
Price & Volume History
Loading chart…
Recent News
Innoviva to Participate in Upcoming Investor Conferences
Business Wire · Sep 2, 2026 12:00 PM
Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
Business Wire · Aug 11, 2026 8:05 PM
How Innoviva’s Q2 Loss and Aggressive Buybacks Could Reshape Capital Allocation for INVA Investors
Simply Wall St. · Aug 7, 2026 11:12 PM
Innoviva (INVA) Q2 Earnings and Revenues Top Estimates
Zacks · Aug 6, 2026 12:35 AM
Innoviva: Q2 Earnings Snapshot
Associated Press · Aug 5, 2026 9:59 PM
Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress
Business Wire · Aug 5, 2026 8:05 PM
Is Innoviva (INVA) One of the Best Cheap Small Cap Stocks to Buy Now?
Insider Monkey · Jul 1, 2026 7:36 PM
Innoviva, Inc. (INVA) Launches Nortiva Bio to Advance Long-Acting Oral Drug Platform
Insider Monkey · Jun 25, 2026 12:42 PM
Innoviva Specialty Therapeutics (INVA) Partners With Dr. Reddy’s to Expand XACDURO Access Internationally
Insider Monkey · Jun 23, 2026 5:54 PM
Nortiva Bio Launches to Develop Long-Acting Oral Medicines
Business Wire · Jun 18, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See INVA's money flow as a full page
Social Sentiment
Avg +0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.